Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL752528 | 1.00 | MEN1 (0.32) | MEN1KMT2APPARD | |
| SCHEMBL731483 | 1.00 | MEN1 (0.32) | MEN1KMT2APPARD | |
| SCHEMBL8272949 | 0.83 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL1167081 | 0.83 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL730999 | 0.83 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL749109 | 0.83 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL12507004 | 0.82 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL12777410 | 0.82 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL1167084 | 0.79 | LAP3 (0.30) | — | |
| SCHEMBL12028111 | 0.79 | MEN1 (0.33) | MEN1KMT2APPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311077-A1 | Antiviral Compounds | GILEAD SCIENCES, INC. | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311077-A1 | Antiviral Compounds | EIF2AK2, MAVS, ITPA | MEN1 3603/4885KMT2A 3924/4885PPARD 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.